Correspondingly, ART1 blockade with a therapeutic monoclonal antibody (22C12) reduced the growth and dissemination of ART1 expressing tumours in mice and promoted tumour infiltration of activated P2X7R+ CD8 T cells (Figure 1) (55). Here, CD8A is linked to neoplasm.